Jyong Biotech LTD

F-120-F13D

Schedule 13D - Activist Investments

NASDAQ
MENS
Jyong Biotech LTD
SCHEDULE: Jyong Biotech: Major Shareholder Files Schedule 13D
Ms. Kuo Fu-Feng and associated entities disclose a 33.34% beneficial ownership stake in Jyong Biotech Ltd.